| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | FAT3 CDH23 PCDHA12 PCDHA2 RHOT2 RET PKD1L2 PCDH20 GSN NELL2 FAT1 THBS4 FAT2 ACAN VCAN CABS1 DCHS1 LRP4 ANXA9 SYT13 CDH13 | 2.22e-06 | 749 | 173 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ITGA11 GAPVD1 OBSCN ITGA10 CDH23 ACVR1 ITGAX DSCAML1 TGFBI THBS4 DCHS1 BZW1 FERMT2 TNR TNXB CDH13 | 6.83e-05 | 599 | 173 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | collagen binding | 7.35e-05 | 81 | 173 | 6 | GO:0005518 | |
| GeneOntologyMolecularFunction | integrin binding | 1.47e-04 | 175 | 173 | 8 | GO:0005178 | |
| GeneOntologyMolecularFunction | collagen fibril binding | 2.23e-04 | 3 | 173 | 2 | GO:0098633 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 5.65e-04 | 268 | 173 | 9 | GO:0005539 | |
| GeneOntologyMolecularFunction | opsin binding | 7.34e-04 | 5 | 173 | 2 | GO:0002046 | |
| GeneOntologyMolecularFunction | collagen binding involved in cell-matrix adhesion | 7.34e-04 | 5 | 173 | 2 | GO:0098639 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 7.34e-04 | 5 | 173 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 7.58e-04 | 21 | 173 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 8.64e-04 | 85 | 173 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 9.96e-04 | 23 | 173 | 3 | GO:0030021 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT3 CDH23 PCDHA12 PCDHA2 IGSF11 RET DSCAML1 PCDH20 PTK7 FAT1 FAT2 DCHS1 NECTIN4 CDH13 | 5.89e-10 | 187 | 172 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT3 CDH23 PCDHA12 PCDHA2 IGSF11 ACVR1 RET DSCAML1 PCDH20 PTK7 IL1RAPL1 FAT1 FAT2 DCHS1 NECTIN4 CDH13 | 8.75e-09 | 313 | 172 | 16 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SELPLG ITGA11 KIF26B FAT3 ITGA10 CDH23 PCDHA12 FNDC3A PCDHA2 IGSF11 ACVR1 RET ITGAX DSCAML1 PCDH20 PTK7 IL1RAPL1 FAT1 THBS4 FAT2 DCHS1 NECTIN4 COL14A1 ANXA9 TNR TNXB CDH13 | 2.92e-07 | 1077 | 172 | 27 | GO:0098609 |
| GeneOntologyCellularComponent | perineuronal net | 9.37e-07 | 10 | 174 | 4 | GO:0072534 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.46e-06 | 11 | 174 | 4 | GO:0098966 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 3.13e-06 | 13 | 174 | 4 | GO:0099535 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.31e-04 | 59 | 174 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | tenascin complex | 4.09e-04 | 4 | 174 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | cell-cell junction | JCAD EPPK1 OBSCN PCDHA12 IGSF11 GSN PTK7 FAT1 FAT2 PARD6A NECTIN4 SGSM3 FERMT2 CDH13 | 4.43e-04 | 591 | 174 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | cell body | PCSK1 CACNA1C ATP7A CRTC1 CCT7 CCT2 RET PTGER4 RGS12 AKAP12 PTK7 PPARGC1A DLGAP3 NELL2 PARD6A ACAN LRP4 SOD1 | 7.66e-04 | 929 | 174 | 18 | GO:0044297 |
| HumanPheno | Upper limb muscle weakness | SH3TC2 B4GALNT1 OBSCN LPIN1 PPARGC1A FGD4 TREM2 LRP4 MUSK SOD1 | 3.04e-06 | 151 | 54 | 10 | HP:0003484 |
| HumanPheno | Tongue atrophy | 1.50e-05 | 52 | 54 | 6 | HP:0012473 | |
| HumanPheno | Fatigable weakness | 3.35e-05 | 121 | 54 | 8 | HP:0003473 | |
| HumanPheno | Abnormal synaptic transmission at the neuromuscular junction | 3.56e-05 | 122 | 54 | 8 | HP:0003398 | |
| HumanPheno | Abnormal peripheral nervous system synaptic transmission | 3.56e-05 | 122 | 54 | 8 | HP:0030191 | |
| HumanPheno | Abnormal synaptic transmission | 3.56e-05 | 122 | 54 | 8 | HP:0012535 | |
| HumanPheno | Fatigable weakness of swallowing muscles | 7.00e-05 | 42 | 54 | 5 | HP:0030195 | |
| HumanPheno | Cutaneous syndactyly | 9.14e-05 | 103 | 54 | 7 | HP:0012725 | |
| HumanPheno | Cutaneous finger syndactyly | 9.76e-05 | 72 | 54 | 6 | HP:0010554 | |
| HumanPheno | Lattice corneal dystrophy | 1.10e-04 | 2 | 54 | 2 | HP:0001149 | |
| HumanPheno | Cranial nerve compression | 1.80e-04 | 51 | 54 | 5 | HP:0001293 | |
| HumanPheno | Truncal obesity | 2.02e-04 | 82 | 54 | 6 | HP:0001956 | |
| HumanPheno | Skeletal muscle atrophy | SH3TC2 ERBB3 B4GALNT1 ATP7A KLHL40 BBS2 CDH23 WDPCP PPARGC1A FGD4 TREM2 LRP4 TNR TNXB MUSK SOD1 | 2.11e-04 | 579 | 54 | 16 | HP:0003202 |
| MousePheno | abnormal lung size | ATP7A WWTR1 THOC2 PTGER4 CREBBP PPARGC1A ACAN DCHS1 LRP4 KCNAB3 | 1.34e-05 | 174 | 145 | 10 | MP:0004881 |
| Domain | Cadherin | 9.26e-08 | 113 | 172 | 10 | PF00028 | |
| Domain | CADHERIN_2 | 1.01e-07 | 114 | 172 | 10 | PS50268 | |
| Domain | - | 1.01e-07 | 114 | 172 | 10 | 2.60.40.60 | |
| Domain | CA | 1.09e-07 | 115 | 172 | 10 | SM00112 | |
| Domain | Cadherin-like | 1.19e-07 | 116 | 172 | 10 | IPR015919 | |
| Domain | Cadherin | 1.40e-07 | 118 | 172 | 10 | IPR002126 | |
| Domain | Cadherin_CS | 7.48e-07 | 109 | 172 | 9 | IPR020894 | |
| Domain | CADHERIN_1 | 1.02e-06 | 113 | 172 | 9 | PS00232 | |
| Domain | Laminin_G | 1.52e-05 | 58 | 172 | 6 | IPR001791 | |
| Domain | FG-GAP | 6.39e-05 | 24 | 172 | 4 | PF01839 | |
| Domain | FG-GAP | 6.39e-05 | 24 | 172 | 4 | IPR013517 | |
| Domain | EGF | 6.64e-05 | 235 | 172 | 10 | SM00181 | |
| Domain | EGF_3 | 6.64e-05 | 235 | 172 | 10 | PS50026 | |
| Domain | TFIID_sub1_DUF3591 | 8.43e-05 | 2 | 172 | 2 | IPR022591 | |
| Domain | TBP-binding | 8.43e-05 | 2 | 172 | 2 | PF09247 | |
| Domain | ARHGEF5_35 | 8.43e-05 | 2 | 172 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 8.43e-05 | 2 | 172 | 2 | IPR029212 | |
| Domain | DUF3591 | 8.43e-05 | 2 | 172 | 2 | PF12157 | |
| Domain | TAF_II_230-bd | 8.43e-05 | 2 | 172 | 2 | IPR009067 | |
| Domain | - | 8.43e-05 | 2 | 172 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 8.43e-05 | 2 | 172 | 2 | IPR011177 | |
| Domain | Bromodomain_CS | 8.86e-05 | 26 | 172 | 4 | IPR018359 | |
| Domain | WD40_repeat_dom | DCAF1 CFAP251 UBR4 BBS2 SPAG9 WDFY4 WDPCP DMXL1 SF3B3 TBC1D31 ANAPC4 | 9.99e-05 | 297 | 172 | 11 | IPR017986 |
| Domain | EGF-like_dom | 1.07e-04 | 249 | 172 | 10 | IPR000742 | |
| Domain | EGF_1 | 1.30e-04 | 255 | 172 | 10 | PS00022 | |
| Domain | EGF_CA | 1.37e-04 | 122 | 172 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.52e-04 | 124 | 172 | 7 | IPR001881 | |
| Domain | EGF-like_CS | 1.58e-04 | 261 | 172 | 10 | IPR013032 | |
| Domain | VWA | 1.63e-04 | 56 | 172 | 5 | PF00092 | |
| Domain | EGF | 1.67e-04 | 126 | 172 | 7 | PF00008 | |
| Domain | EGF_2 | 1.78e-04 | 265 | 172 | 10 | PS01186 | |
| Domain | EGF_Ca-bd_CS | 2.76e-04 | 97 | 172 | 6 | IPR018097 | |
| Domain | WD40/YVTN_repeat-like_dom | DCAF1 CFAP251 BBS2 SPAG9 BIRC6 WDFY4 WDPCP DMXL1 SF3B3 TBC1D31 ANAPC4 | 2.84e-04 | 335 | 172 | 11 | IPR015943 |
| Domain | EGF_CA | 3.09e-04 | 99 | 172 | 6 | PS01187 | |
| Domain | BROMODOMAIN_1 | 3.62e-04 | 37 | 172 | 4 | PS00633 | |
| Domain | Bromodomain | 4.02e-04 | 38 | 172 | 4 | PF00439 | |
| Domain | - | LRFN1 MYCBP2 OBSCN FNDC3A IGSF11 DSCAML1 PTK7 HAPLN1 IL1RAPL1 VCAN TREM2 NECTIN4 COL14A1 TNR TNXB MUSK | 4.27e-04 | 663 | 172 | 16 | 2.60.40.10 |
| Domain | Laminin_G_2 | 4.90e-04 | 40 | 172 | 4 | PF02210 | |
| Domain | BROMODOMAIN_2 | 5.39e-04 | 41 | 172 | 4 | PS50014 | |
| Domain | Integrin_alpha-2 | 5.66e-04 | 18 | 172 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 5.66e-04 | 18 | 172 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 5.66e-04 | 18 | 172 | 3 | PF08441 | |
| Domain | Integrin_alpha | 5.66e-04 | 18 | 172 | 3 | IPR000413 | |
| Domain | Bromodomain | 5.92e-04 | 42 | 172 | 4 | IPR001487 | |
| Domain | BROMO | 5.92e-04 | 42 | 172 | 4 | SM00297 | |
| Domain | - | 5.92e-04 | 42 | 172 | 4 | 1.20.920.10 | |
| Domain | Int_alpha | 6.67e-04 | 19 | 172 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 6.67e-04 | 19 | 172 | 3 | IPR013519 | |
| Domain | LamG | 7.07e-04 | 44 | 172 | 4 | SM00282 | |
| Domain | fn3 | 7.66e-04 | 162 | 172 | 7 | PF00041 | |
| Domain | Ig-like_fold | LRFN1 MYCBP2 OBSCN FNDC3A IGSF11 DSCAML1 PTK7 HAPLN1 IL1RAPL1 VCAN TREM2 NECTIN4 COL14A1 TNR TNXB MUSK | 8.39e-04 | 706 | 172 | 16 | IPR013783 |
| Domain | VWFA | 9.62e-04 | 82 | 172 | 5 | PS50234 | |
| Domain | FG_GAP | 1.04e-03 | 22 | 172 | 3 | PS51470 | |
| Domain | - | DCAF1 CFAP251 BBS2 SPAG9 BIRC6 WDFY4 WDPCP DMXL1 TBC1D31 ANAPC4 | 1.06e-03 | 333 | 172 | 10 | 2.130.10.10 |
| Domain | VWA | 1.07e-03 | 84 | 172 | 5 | SM00327 | |
| Domain | TSPN | 1.19e-03 | 23 | 172 | 3 | SM00210 | |
| Domain | EGF_CA | 1.19e-03 | 86 | 172 | 5 | PF07645 | |
| Domain | Integrin_dom | 1.52e-03 | 25 | 172 | 3 | IPR032695 | |
| Domain | IGc2 | 1.53e-03 | 235 | 172 | 8 | SM00408 | |
| Domain | Ig_sub2 | 1.53e-03 | 235 | 172 | 8 | IPR003598 | |
| Domain | FN3 | 1.66e-03 | 185 | 172 | 7 | SM00060 | |
| Domain | IG | LRFN1 OBSCN IGSF11 DSCAML1 PTK7 HAPLN1 IL1RAPL1 VCAN TREM2 NECTIN4 MUSK | 1.85e-03 | 421 | 172 | 11 | SM00409 |
| Domain | Ig_sub | LRFN1 OBSCN IGSF11 DSCAML1 PTK7 HAPLN1 IL1RAPL1 VCAN TREM2 NECTIN4 MUSK | 1.85e-03 | 421 | 172 | 11 | IPR003599 |
| Domain | - | 1.86e-03 | 95 | 172 | 5 | 2.60.120.200 | |
| Domain | Ig_I-set | 1.93e-03 | 190 | 172 | 7 | IPR013098 | |
| Domain | I-set | 1.93e-03 | 190 | 172 | 7 | PF07679 | |
| Domain | PROTEIN_KINASE_TYR | 2.04e-03 | 97 | 172 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.04e-03 | 97 | 172 | 5 | IPR008266 | |
| Domain | VWF_A | 2.23e-03 | 99 | 172 | 5 | IPR002035 | |
| Domain | ASX_HYDROXYL | 2.33e-03 | 100 | 172 | 5 | PS00010 | |
| Domain | FN3 | 2.50e-03 | 199 | 172 | 7 | PS50853 | |
| Domain | Ig_V-set | 2.50e-03 | 199 | 172 | 7 | IPR013106 | |
| Domain | Chaprnin_Cpn60 | 2.91e-03 | 9 | 172 | 2 | IPR001844 | |
| Domain | Chaperonin_TCP-1_CS | 2.91e-03 | 9 | 172 | 2 | IPR002194 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.00e-03 | 106 | 172 | 5 | IPR000152 | |
| Domain | Growth_fac_rcpt_ | 3.26e-03 | 156 | 172 | 6 | IPR009030 | |
| Domain | FN3_dom | 3.28e-03 | 209 | 172 | 7 | IPR003961 | |
| Domain | TCP1_1 | 3.61e-03 | 10 | 172 | 2 | PS00750 | |
| Domain | TCP1_2 | 3.61e-03 | 10 | 172 | 2 | PS00751 | |
| Domain | TCP1_3 | 3.61e-03 | 10 | 172 | 2 | PS00995 | |
| Domain | Chaperone_TCP-1 | 3.61e-03 | 10 | 172 | 2 | IPR017998 | |
| Domain | ConA-like_dom | 4.24e-03 | 219 | 172 | 7 | IPR013320 | |
| Domain | - | 4.39e-03 | 11 | 172 | 2 | 3.30.260.10 | |
| Domain | TCP-1-like_intermed | 4.39e-03 | 11 | 172 | 2 | IPR027410 | |
| Domain | VWFC_2 | 5.11e-03 | 38 | 172 | 3 | PS50184 | |
| Domain | VWC | 5.11e-03 | 38 | 172 | 3 | SM00214 | |
| Domain | LAM_G_DOMAIN | 5.11e-03 | 38 | 172 | 3 | PS50025 | |
| Domain | ABC_A | 5.24e-03 | 12 | 172 | 2 | IPR026082 | |
| Domain | IG_LIKE | LRFN1 OBSCN IGSF11 DSCAML1 PTK7 HAPLN1 IL1RAPL1 VCAN TREM2 NECTIN4 MUSK | 5.90e-03 | 491 | 172 | 11 | PS50835 |
| Domain | Link_dom | 6.15e-03 | 13 | 172 | 2 | IPR000538 | |
| Domain | Xlink | 6.15e-03 | 13 | 172 | 2 | PF00193 | |
| Domain | LINK_2 | 6.15e-03 | 13 | 172 | 2 | PS50963 | |
| Domain | LINK | 6.15e-03 | 13 | 172 | 2 | SM00445 | |
| Domain | LINK_1 | 6.15e-03 | 13 | 172 | 2 | PS01241 | |
| Domain | VWF_dom | 6.77e-03 | 42 | 172 | 3 | IPR001007 | |
| Domain | Ig-like_dom | LRFN1 OBSCN IGSF11 DSCAML1 PTK7 HAPLN1 IL1RAPL1 VCAN TREM2 NECTIN4 MUSK | 7.02e-03 | 503 | 172 | 11 | IPR007110 |
| Domain | GROEL-like_equatorial | 7.13e-03 | 14 | 172 | 2 | IPR027413 | |
| Domain | - | 7.13e-03 | 14 | 172 | 2 | 1.10.560.10 | |
| Domain | GroEL-like_apical_dom | 8.18e-03 | 15 | 172 | 2 | IPR027409 | |
| Domain | Cpn60/TCP-1 | 8.18e-03 | 15 | 172 | 2 | IPR002423 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.69e-07 | 76 | 130 | 8 | M27219 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.31e-06 | 47 | 130 | 6 | MM14925 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ITGA11 ITGA10 ITGAX HAPLN1 ACAN VCAN LRP4 COL14A1 TNR TNXB MUSK | 1.04e-04 | 300 | 130 | 11 | M610 |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 1.41e-04 | 86 | 130 | 6 | M2642 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | GAPVD1 EPPK1 ZBTB33 UBR4 HMGXB4 CCT2 NFATC2IP ASNS NCAPD2 UMPS BOD1L1 TAF1 BZW1 | 1.70e-08 | 332 | 176 | 13 | 32786267 |
| Pubmed | 2.19e-08 | 7 | 176 | 4 | 16059920 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ERBB3 CFAP251 MYCBP2 ABCA13 UBR4 HMGXB4 CDH23 CRTC1 PKD1L2 FAT1 ZFP91 DNAH6 ATP4A | 4.54e-08 | 361 | 176 | 13 | 26167880 |
| Pubmed | Link protein has greater affinity for versican than aggrecan. | 1.27e-07 | 3 | 176 | 3 | 14724283 | |
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 15590670 | ||
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 1.27e-07 | 3 | 176 | 3 | 15744052 | |
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 24625978 | ||
| Pubmed | Distinct interaction of versican/PG-M with hyaluronan and link protein. | 1.27e-07 | 3 | 176 | 3 | 12888576 | |
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 14620382 | ||
| Pubmed | 3.04e-07 | 12 | 176 | 4 | 10101119 | ||
| Pubmed | High-throughput microarray detection of olfactory receptor gene expression in the mouse. | 5.08e-07 | 4 | 176 | 3 | 15377787 | |
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 26621125 | ||
| Pubmed | 8.53e-07 | 146 | 176 | 8 | 27068509 | ||
| Pubmed | 1.26e-06 | 5 | 176 | 3 | 11038354 | ||
| Pubmed | GAPVD1 KIF26B UBR4 RNF19B NCKIPSD CCT2 ZYG11B DSCAML1 AKAP12 LPIN1 FAT1 GARIN3 EHBP1L1 UMPS TAF1L | 2.58e-06 | 689 | 176 | 15 | 36543142 | |
| Pubmed | GAPVD1 ZBTB33 MYCBP2 MCM7 CCT2 WWTR1 SPAG9 THOC2 CREBBP BAZ2A NCAPD2 BOD1L1 TAF1 | 5.01e-06 | 549 | 176 | 13 | 38280479 | |
| Pubmed | 6.22e-06 | 24 | 176 | 4 | 25344368 | ||
| Pubmed | Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. | 7.38e-06 | 25 | 176 | 4 | 8889551 | |
| Pubmed | GAPVD1 ZBTB33 ZFYVE16 MYCBP2 UBR4 ZNF507 CRTC1 MCM7 RNF40 BIRC6 TAF1 | 1.03e-05 | 418 | 176 | 11 | 34709266 | |
| Pubmed | GAPVD1 BMP2K ZNF507 OBSCN CRTC1 TACC2 RHOT2 THOC2 TTC3 ZNF496 WDFY4 AKAP12 PPARGC1A TBC1D31 VCAN BOD1L1 FERMT2 SOD1 | 1.09e-05 | 1084 | 176 | 18 | 11544199 | |
| Pubmed | 1.26e-05 | 210 | 176 | 8 | 16537572 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.31e-05 | 101 | 176 | 6 | 20551380 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | STARD13 DCAF1 GAPVD1 LRFN1 MYCBP2 BBS2 CDH23 CRTC1 MCM7 ZYG11B E2F5 SPAG9 CREBBP AKAP12 GSN OXA1L SF3B3 COL14A1 BZW1 FERMT2 | 1.33e-05 | 1321 | 176 | 20 | 27173435 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ENGASE LRFN1 EPPK1 MYCBP2 UBR4 OBSCN RNF40 RHOT2 ZNF236 TTC3 BIRC6 PLEKHM1 FAT1 EHBP1L1 SLC2A4RG NCAPD2 TIGD3 LRP4 | 1.41e-05 | 1105 | 176 | 18 | 35748872 |
| Pubmed | 1.49e-05 | 10 | 176 | 3 | 2055107 | ||
| Pubmed | 1.73e-05 | 106 | 176 | 6 | 18654987 | ||
| Pubmed | SMG1 GAPVD1 ZNF507 CRTC1 FNDC3A RNF40 NACAD ANKH SF3B3 NCAPD2 LRP4 SYT13 | 1.79e-05 | 529 | 176 | 12 | 14621295 | |
| Pubmed | Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. | 2.04e-05 | 11 | 176 | 3 | 20404343 | |
| Pubmed | Dlec1 is required for spermatogenesis and male fertility in mice. | 2.04e-05 | 11 | 176 | 3 | 33144677 | |
| Pubmed | 2.04e-05 | 11 | 176 | 3 | 38750698 | ||
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 2.35e-05 | 67 | 176 | 5 | 21875946 | |
| Pubmed | 2.42e-05 | 167 | 176 | 7 | 22159717 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | GAPVD1 KIF26B UBR4 OBSCN MUC19 SPAG9 BIRC6 TMEM132B DSCAML1 THBS4 ASNS CHRD BOD1L1 TNR | 2.53e-05 | 736 | 176 | 14 | 29676528 |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 10198161 | ||
| Pubmed | Identification and characterization of versican/PG-M aggregates in cartilage. | 2.55e-05 | 2 | 176 | 2 | 16648631 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 11932252 | ||
| Pubmed | Diagnostic and clinical classification of autoimmune myasthenia gravis. | 2.55e-05 | 2 | 176 | 2 | 24530233 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 38804708 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 22842574 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 20470874 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 27571988 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 34403156 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 14622116 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 35788130 | ||
| Pubmed | PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. | 2.55e-05 | 2 | 176 | 2 | 15522894 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 38702076 | ||
| Pubmed | Meprin β cleaves TREM2 and controls its phagocytic activity on macrophages. | 2.55e-05 | 2 | 176 | 2 | 32237095 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25356636 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 36259452 | ||
| Pubmed | Neuronal LRP4 regulates synapse formation in the developing CNS. | 2.55e-05 | 2 | 176 | 2 | 29061639 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 18047418 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19666486 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 10070062 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 30528255 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 30385274 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 35013104 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12746407 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 27297501 | ||
| Pubmed | MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. | 2.55e-05 | 2 | 176 | 2 | 24297891 | |
| Pubmed | 2.71e-05 | 12 | 176 | 3 | 18296617 | ||
| Pubmed | 3.51e-05 | 13 | 176 | 3 | 7805729 | ||
| Pubmed | 4.97e-05 | 187 | 176 | 7 | 26460568 | ||
| Pubmed | DCAF1 ZBTB33 DCDC1 FAT3 HMGXB4 RHOT2 CREBBP NELL2 FAT1 SF3B3 BAZ2A ZFP91 LRP4 XYLB TAF1 UNC80 ANAPC4 | 5.67e-05 | 1116 | 176 | 17 | 31753913 | |
| Pubmed | Genetic predictors of fibrin D-dimer levels in healthy adults. | 6.80e-05 | 16 | 176 | 3 | 21502573 | |
| Pubmed | DCAF1 ATP7A MYCBP2 GRAMD1A UBR4 BBS2 FNDC3A TTC3 AKAP12 DMXL1 PTK7 OXA1L SF3B3 TBC1D31 BAZ2A ASNS COL14A1 FERMT2 MMAB SOD1 | 6.98e-05 | 1487 | 176 | 20 | 33957083 | |
| Pubmed | GAPVD1 ZBTB33 ATP7A ZFYVE16 FNDC3A CCT7 CCT2 AKAP12 SF3B3 NCAPD2 BOD1L1 BZW1 FERMT2 | 7.06e-05 | 708 | 176 | 13 | 39231216 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 29848346 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 10343159 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 19669783 | ||
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 7.61e-05 | 3 | 176 | 2 | 7694605 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 31358736 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 24244707 | ||
| Pubmed | FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation. | 7.61e-05 | 3 | 176 | 2 | 26104008 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 21969364 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 11597768 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 9294172 | ||
| Pubmed | Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. | 7.61e-05 | 3 | 176 | 2 | 10400671 | |
| Pubmed | MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer. | 7.61e-05 | 3 | 176 | 2 | 27797825 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 34023501 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 26595521 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 7530141 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 36403758 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 27391159 | ||
| Pubmed | Kindlin-2 regulates mesenchymal stem cell differentiation through control of YAP1/TAZ. | 7.61e-05 | 3 | 176 | 2 | 29496737 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 16822332 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 17822691 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 25247420 | ||
| Pubmed | Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection. | 7.61e-05 | 3 | 176 | 2 | 29515038 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 32640908 | ||
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 7.61e-05 | 3 | 176 | 2 | 11592977 | |
| Pubmed | TGFBI, CHST6, and GSN gene analysis in Mexican patients with stromal corneal dystrophies. | 7.61e-05 | 3 | 176 | 2 | 24801599 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 37292436 | ||
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 12217962 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 7.61e-05 | 3 | 176 | 2 | 16407123 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.84e-05 | 86 | 176 | 5 | 28327460 | |
| Pubmed | 8.22e-05 | 17 | 176 | 3 | 22183742 | ||
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 9.83e-05 | 18 | 176 | 3 | 33108146 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.26e-04 | 95 | 176 | 5 | 29643511 | |
| Pubmed | 1.36e-04 | 20 | 176 | 3 | 26116666 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.39e-04 | 97 | 176 | 5 | 27559042 | |
| Interaction | PPM1M interactions | 2.99e-07 | 53 | 170 | 7 | int:PPM1M | |
| Interaction | XAGE1A interactions | 1.16e-06 | 41 | 170 | 6 | int:XAGE1A | |
| Interaction | DCANP1 interactions | 1.72e-05 | 19 | 170 | 4 | int:DCANP1 | |
| Cytoband | 1q44 | 6.91e-05 | 110 | 176 | 5 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 1.41e-04 | 128 | 176 | 5 | chr1q44 | |
| GeneFamily | Cadherin related | 1.30e-09 | 17 | 128 | 6 | 24 | |
| GeneFamily | Fibronectin type III domain containing | 1.44e-04 | 160 | 128 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.49e-04 | 161 | 128 | 7 | 593 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.62e-04 | 18 | 128 | 3 | 1160 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.96e-04 | 4 | 128 | 2 | 574 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.23e-03 | 66 | 128 | 4 | 722 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 1.73e-03 | 9 | 128 | 2 | 207 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.83e-03 | 40 | 128 | 3 | 321 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.04e-03 | 41 | 128 | 3 | 1298 | |
| GeneFamily | ATP binding cassette subfamily A | 4.28e-03 | 14 | 128 | 2 | 805 | |
| GeneFamily | Chaperonins | 4.92e-03 | 15 | 128 | 2 | 587 | |
| Coexpression | GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP | 7.37e-06 | 200 | 172 | 9 | M8200 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | AMBP CACNA1C ERBB3 UTS2R PTGER4 WDPCP AKAP12 MEP1B DLGAP3 NELL2 THBS4 FAT2 FGD4 ACAN DCHS1 BOD1L1 TNR DNAH6 KCNAB3 TNXB ATP4A MUSK SOD1 | 1.17e-05 | 1281 | 172 | 23 | M1884 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | JCAD SH3TC2 ITGA11 ERBB3 RNF19B CDH23 HPS3 TGFBI PPARGC1A FAT1 CLCA1 VCAN LRP4 COL14A1 | 1.24e-05 | 441 | 169 | 14 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200 | 1.26e-05 | 177 | 169 | 9 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | SLC24A5 JCAD SH3TC2 ITGA11 ERBB3 ATP7A TMC7 BMP2K RNF19B CDH23 PPM1K HPS3 TGFBI PPARGC1A FAT1 CLCA1 FGD4 VCAN ASNS COL14A1 | 2.44e-05 | 880 | 169 | 20 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500 | 5.85e-05 | 123 | 169 | 7 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SMG1 SP4 ZBTB33 ZNF507 BBS2 FNDC3A ZYG11B PPARGC1A NELL2 TBC1D31 ZFP91 TIGD3 BOD1L1 XYLB TAF1 | 8.61e-05 | 595 | 169 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ATP7A KIF26B FAT3 RNF19B E2F5 ACVR1 PPM1K PTGER4 PCDH20 HAPLN1 TGFBI PPARGC1A CLCA1 VCAN ASNS NCAPD2 DCHS1 COL14A1 | 1.10e-04 | 827 | 169 | 18 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OTOA ABCA4 ABCA13 KIF26B FAT3 OBSCN PKD1L2 DSCAML1 PPARGC1A FAT1 UNC80 | 1.78e-10 | 184 | 174 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OTOA ABCA4 ABCA13 KIF26B FAT3 OBSCN PKD1L2 DSCAML1 PPARGC1A FAT1 UNC80 | 1.78e-10 | 184 | 174 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OTOA ABCA4 ABCA13 KIF26B FAT3 OBSCN PKD1L2 DSCAML1 PPARGC1A FAT1 UNC80 | 1.78e-10 | 184 | 174 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | CACNA1C OBSCN FNDC3A TACC2 ANKH IL1RAPL1 PPARGC1A FAT1 CDH13 | 6.33e-08 | 190 | 174 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.41e-08 | 199 | 174 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-07 | 155 | 174 | 8 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.37e-07 | 174 | 174 | 8 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.65e-07 | 180 | 174 | 8 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.89e-07 | 181 | 174 | 8 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.89e-07 | 181 | 174 | 8 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.56e-07 | 193 | 174 | 8 | 5f732598cdb6f3bd519f044a9cc553bd2e8b1052 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 196 | 174 | 8 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 196 | 174 | 8 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.20e-06 | 199 | 174 | 8 | 6c0354f57883330c685a8d9d5d3014ace7eca584 | |
| ToppCell | (2)_Fibroblasts|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.20e-06 | 199 | 174 | 8 | 777423b413376b0d3fbd92ff51dd0133fb54d293 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-06 | 199 | 174 | 8 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-06 | 200 | 174 | 8 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-06 | 200 | 174 | 8 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-06 | 200 | 174 | 8 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.68e-06 | 163 | 174 | 7 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.15e-06 | 166 | 174 | 7 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 168 | 174 | 7 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 173 | 174 | 7 | 4e9b6c71030ae0d63d54e7255e4a10b25970fcc4 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.87e-06 | 175 | 174 | 7 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.87e-06 | 175 | 174 | 7 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.87e-06 | 175 | 174 | 7 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.09e-06 | 176 | 174 | 7 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 6.56e-06 | 178 | 174 | 7 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.80e-06 | 179 | 174 | 7 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 7.06e-06 | 180 | 174 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 180 | 174 | 7 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.58e-06 | 182 | 174 | 7 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-06 | 183 | 174 | 7 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.16e-06 | 121 | 174 | 6 | 7f2057367777c6c92f596054cbc5fe567d079fbc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.44e-06 | 185 | 174 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.44e-06 | 185 | 174 | 7 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 9.05e-06 | 187 | 174 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.37e-06 | 188 | 174 | 7 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-06 | 188 | 174 | 7 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.70e-06 | 189 | 174 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.84e-06 | 125 | 174 | 6 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.00e-05 | 190 | 174 | 7 | 00ef6ec71353e42260c0d807d7da65b63154c288 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.00e-05 | 190 | 174 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.00e-05 | 190 | 174 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.00e-05 | 190 | 174 | 7 | 18c020ca9a23399214133ec255ab870e0060f2e1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.00e-05 | 190 | 174 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 192 | 174 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.11e-05 | 193 | 174 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.11e-05 | 193 | 174 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 194 | 174 | 7 | 735eee6ef25589f935fa922788ebbdbfef61249e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 194 | 174 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 194 | 174 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.19e-05 | 195 | 174 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.19e-05 | 195 | 174 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 197 | 174 | 7 | 467e7cbf511d3bcc701923603032aaf0bba2736d | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 197 | 174 | 7 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.27e-05 | 197 | 174 | 7 | a183919023a4aca90a06be0e5e89c817b38c5574 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-05 | 131 | 174 | 6 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.31e-05 | 198 | 174 | 7 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 198 | 174 | 7 | 4a4566f86c9365a41b4cfd1609eac09bd73b3f34 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.31e-05 | 198 | 174 | 7 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-05 | 199 | 174 | 7 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-05 | 199 | 174 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-05 | 199 | 174 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 1.35e-05 | 199 | 174 | 7 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 199 | 174 | 7 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 174 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-05 | 200 | 174 | 7 | c0ea7cbc9d5e999530888145ce9e4c232fc874de | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.40e-05 | 200 | 174 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-05 | 200 | 174 | 7 | 14f3fe19b6647b32a5e28d717235741997d8522c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 174 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | (60)_Macrophage|World / shred on Cell_type and subtype | 1.59e-05 | 204 | 174 | 7 | 06d0cb306f1ad0014d81f8228868938e48c2bcf3 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Nfib_(Amygdala)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.75e-05 | 82 | 174 | 5 | ab081620b6113f843fede23da0a18720111ffc7c | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Nfib_(Amygdala)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.75e-05 | 82 | 174 | 5 | 1ca848a18463b1344e23e3ad1b5d01ae27c00586 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-05 | 144 | 174 | 6 | 5e948d4cb913ccd8f82262a1b4d20967aadab3ab | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 149 | 174 | 6 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-05 | 149 | 174 | 6 | a6c24d8f3b5f08587f0a12cd63d166b68ea000c7 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 152 | 174 | 6 | 7e686721b95c837f2b0d5116927c8ecacef055ee | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-05 | 157 | 174 | 6 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-05 | 157 | 174 | 6 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-05 | 157 | 174 | 6 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-05 | 159 | 174 | 6 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-05 | 159 | 174 | 6 | 4b840da854390f8285c219314cff4434d7ffcacc | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-05 | 159 | 174 | 6 | d9e535cf9a0a2302268f2897b010dcecc6426e41 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-05 | 159 | 174 | 6 | 29999c87f5823f734e5cbf8ea8b729ec017db9b3 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.98e-05 | 160 | 174 | 6 | b2d8940ea8c068273b7da1589d3d6ae5110d8209 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.98e-05 | 160 | 174 | 6 | 6215ac6123a295f3c2f033786602a57b2e2e1177 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 160 | 174 | 6 | 8dae9b0cf90a09acb196223f45a14680102630b2 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.98e-05 | 160 | 174 | 6 | 229841be7b984a00a301cd5d88c11226a90d8a88 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.98e-05 | 160 | 174 | 6 | 99c9ae2041445539fada842e1af01368669bfca0 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.98e-05 | 160 | 174 | 6 | 9caab1bb63c7e66c44783852ee75b16bb40fa594 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 4.12e-05 | 161 | 174 | 6 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.26e-05 | 162 | 174 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.26e-05 | 162 | 174 | 6 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.26e-05 | 162 | 174 | 6 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.26e-05 | 162 | 174 | 6 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 164 | 174 | 6 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.88e-05 | 166 | 174 | 6 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | PND01-03-samps-Myeloid|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.88e-05 | 166 | 174 | 6 | 99dc8a186ec12d3563e81fa4618a814740332c73 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-05 | 168 | 174 | 6 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| Disease | growth differentiation factor 15 measurement | 6.58e-06 | 7 | 171 | 3 | EFO_0009181 | |
| Disease | Colorectal Carcinoma | ABCA4 ABCA13 OBSCN RET DSCAML1 AKAP12 HPS3 HAPLN1 LPIN1 FAT1 DCHS1 UMPS TSKS ANAPC4 | 6.42e-05 | 702 | 171 | 14 | C0009402 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | JCAD ERBB3 GAPVD1 DCDC1 CDH23 TACC2 RHOT2 IGSF11 BIRC6 TMEM132B WDPCP THBS4 ASNS KCNAB3 CDH13 | 7.10e-05 | 801 | 171 | 15 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | creatinine measurement | GAPVD1 DCDC1 KIF26B CYP21A2 OBSCN BIRC6 RGS12 PPARGC1A SLC9B1 DLGAP3 RTCA XYLB SGSM3 ANXA9 MUSK UNC80 CDH13 | 7.17e-05 | 995 | 171 | 17 | EFO_0004518 |
| Disease | essential tremor | 1.46e-04 | 136 | 171 | 6 | EFO_0003108 | |
| Disease | risk-taking behaviour | CACNA1C GAPVD1 DCDC1 CDH23 IGSF11 BIRC6 FRAT2 TMEM132B WDPCP ASNS LRP4 KCNAB3 TNXB CDH13 | 1.56e-04 | 764 | 171 | 14 | EFO_0008579 |
| Disease | glycine measurement, amino acid measurement | 1.99e-04 | 4 | 171 | 2 | EFO_0005134, EFO_0009767 | |
| Disease | Squamous cell carcinoma of esophagus | 2.34e-04 | 95 | 171 | 5 | C0279626 | |
| Disease | Disorder of eye | 2.48e-04 | 212 | 171 | 7 | C0015397 | |
| Disease | Intravascular hemolysis | 4.93e-04 | 6 | 171 | 2 | C0235574 | |
| Disease | Hemolysis (disorder) | 4.93e-04 | 6 | 171 | 2 | C0019054 | |
| Disease | level of Phosphatidylcholine (O-18:2_18:2) in blood serum | 4.93e-04 | 6 | 171 | 2 | OBA_2045134 | |
| Disease | level of Phosphatidylcholine (O-16:0_18:2) in blood serum | 4.93e-04 | 6 | 171 | 2 | OBA_2045114 | |
| Disease | Extravascular Hemolysis | 4.93e-04 | 6 | 171 | 2 | C0312854 | |
| Disease | platelet measurement | 5.27e-04 | 315 | 171 | 8 | EFO_0005036 | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 5.63e-04 | 28 | 171 | 3 | DOID:7998 (biomarker_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 6.25e-04 | 29 | 171 | 3 | EFO_0008009 | |
| Disease | unipolar depression | OTOA JCAD SP4 ITGA11 DCDC1 ABCA13 PCDHA2 WDPCP HAPLN1 FAT1 VCAN DCHS1 XYLB TNR DNAH6 SYT13 CDH13 | 6.72e-04 | 1206 | 171 | 17 | EFO_0003761 |
| Disease | D dimer measurement | 6.92e-04 | 30 | 171 | 3 | EFO_0004507 | |
| Disease | intraocular pressure measurement | 8.13e-04 | 509 | 171 | 10 | EFO_0004695 | |
| Disease | aspartate aminotransferase measurement | PCSK1 SP4 ERBB3 ABCA4 CETP OBSCN MUC19 BIRC6 PLEKHM1 LPIN1 PPARGC1A BAZ2A ANXA9 NPAS2 | 8.32e-04 | 904 | 171 | 14 | EFO_0004736 |
| Disease | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement | 9.14e-04 | 8 | 171 | 2 | EFO_0800610 | |
| Disease | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement | 9.14e-04 | 8 | 171 | 2 | EFO_0800396 | |
| Disease | 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) measurement | 9.14e-04 | 8 | 171 | 2 | EFO_0800423 | |
| Disease | 1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1) measurement | 9.14e-04 | 8 | 171 | 2 | EFO_0800420 | |
| Disease | citrate measurement | 1.17e-03 | 79 | 171 | 4 | EFO_0010114 | |
| Disease | zinc fingers and homeoboxes protein 3 measurement | 1.17e-03 | 9 | 171 | 2 | EFO_0803299 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.45e-03 | 286 | 171 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | Anemia, Sickle Cell | 1.46e-03 | 10 | 171 | 2 | C0002895 | |
| Disease | Odontome | 1.46e-03 | 10 | 171 | 2 | C0524730 | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 1.46e-03 | 10 | 171 | 2 | EFO_0022035 | |
| Disease | level of Phosphatidylcholine (O-18:2_16:0) in blood serum | 1.46e-03 | 10 | 171 | 2 | OBA_2045132 | |
| Disease | Tooth Abnormalities | 1.46e-03 | 10 | 171 | 2 | C0040427 | |
| Disease | neuroimaging measurement | ERBB3 DCDC1 KIF26B FAT3 CYP21A2 PGPEP1 TACC2 PTK7 HAPLN1 PPARGC1A NELL2 CSRNP2 VCAN UMPS MUSK | 1.46e-03 | 1069 | 171 | 15 | EFO_0004346 |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.73e-03 | 41 | 171 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 1.74e-03 | 88 | 171 | 4 | EFO_0803332 | |
| Disease | neuroticism measurement, cognitive function measurement | CACNA1C ZNF507 PCDHA12 PCDHA2 BIRC6 WDPCP TNR CDH13 ANAPC4 NPAS2 | 1.79e-03 | 566 | 171 | 10 | EFO_0007660, EFO_0008354 |
| Disease | Abnormality of refraction | JCAD SMG1 ABCA4 FAT3 PCDHA12 PCDHA2 IGSF11 BIRC6 DSCAML1 PPARGC1A THBS4 | 1.97e-03 | 673 | 171 | 11 | HP_0000539 |
| Disease | amino acid measurement | ITGA11 DCDC1 ZFYVE16 CYP21A2 WWTR1 TACC2 WDPCP HAPLN1 NELL2 VCAN COL14A1 | 2.09e-03 | 678 | 171 | 11 | EFO_0005134 |
| Disease | metabolite measurement, body weight gain | 2.12e-03 | 12 | 171 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 2.12e-03 | 12 | 171 | 2 | EFO_0800466 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 2.12e-03 | 12 | 171 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | cholesteryl ester 20:5 measurement | 2.13e-03 | 44 | 171 | 3 | EFO_0010349 | |
| Disease | complement factor D measurement | 2.13e-03 | 93 | 171 | 4 | EFO_0020283 | |
| Disease | parental longevity | JCAD GAPVD1 CYP21A2 PGPEP1 PKD1L2 RGS12 PPARGC1A CDH13 ANAPC4 | 2.46e-03 | 494 | 171 | 9 | EFO_0007796 |
| Disease | Charcot-Marie-Tooth disease type 4 | 2.50e-03 | 13 | 171 | 2 | cv:C4082197 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 2.50e-03 | 13 | 171 | 2 | OBA_2045072 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 2.73e-03 | 48 | 171 | 3 | C4551993 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 2.73e-03 | 48 | 171 | 3 | C1862941 | |
| Disease | gastroesophageal reflux disease | 2.87e-03 | 101 | 171 | 4 | EFO_0003948 | |
| Disease | Pneumoconiosis | 2.90e-03 | 14 | 171 | 2 | C0032273 | |
| Disease | Bagassosis | 2.90e-03 | 14 | 171 | 2 | C0004681 | |
| Disease | orotic acid measurement | 2.90e-03 | 14 | 171 | 2 | EFO_0010516 | |
| Disease | thalamus volume change measurement | 2.90e-03 | 14 | 171 | 2 | EFO_0021496 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 2.90e-03 | 14 | 171 | 2 | OBA_2045100 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 3.07e-03 | 50 | 171 | 3 | C1862939 | |
| Disease | melanoma | 3.33e-03 | 248 | 171 | 6 | C0025202 | |
| Disease | Muscular Atrophy | 3.34e-03 | 15 | 171 | 2 | C0026846 | |
| Disease | phosphatidylcholine 36:3 measurement | 3.34e-03 | 15 | 171 | 2 | EFO_0010381 | |
| Disease | response to olanzapine | 3.34e-03 | 15 | 171 | 2 | GO_0097333 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 3.34e-03 | 15 | 171 | 2 | OBA_2045131 | |
| Disease | Neurogenic Muscular Atrophy | 3.34e-03 | 15 | 171 | 2 | C0270948 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 3.34e-03 | 15 | 171 | 2 | OBA_2045067 | |
| Disease | high density lipoprotein cholesterol measurement, metabolic syndrome | 3.34e-03 | 15 | 171 | 2 | EFO_0000195, EFO_0004612 | |
| Disease | hemoglobin A1 measurement | 3.45e-03 | 520 | 171 | 9 | EFO_0007629 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 3.80e-03 | 16 | 171 | 2 | OBA_2045090 | |
| Disease | Alzheimer disease, age at onset | 3.99e-03 | 343 | 171 | 7 | EFO_0004847, MONDO_0004975 | |
| Disease | lipoprotein A measurement | 4.16e-03 | 112 | 171 | 4 | EFO_0006925 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 4.18e-03 | 346 | 171 | 7 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | plasma beta-amyloid 1-40 measurement | 4.29e-03 | 17 | 171 | 2 | EFO_0005659 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 4.29e-03 | 17 | 171 | 2 | C2936862 | |
| Disease | laryngeal squamous cell carcinoma | 4.29e-03 | 17 | 171 | 2 | EFO_0006352 | |
| Disease | hyperglycemia (implicated_via_orthology) | 4.29e-03 | 17 | 171 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | Limb Deformities, Congenital | 4.29e-03 | 17 | 171 | 2 | C0206762 | |
| Disease | antihyperlipidemic drug use measurement | 4.57e-03 | 115 | 171 | 4 | EFO_0803367 | |
| Disease | Amyotrophic Lateral Sclerosis | 4.67e-03 | 58 | 171 | 3 | C0002736 | |
| Disease | platelet component distribution width | CACNA1C JCAD SH3TC2 GAPVD1 BMP2K CYP21A2 ZNF496 BAZ2A TNXB MUSK NPAS2 | 4.71e-03 | 755 | 171 | 11 | EFO_0007984 |
| Disease | cognitive function measurement, self reported educational attainment | 4.80e-03 | 355 | 171 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | Bardet-Biedl syndrome | 4.81e-03 | 18 | 171 | 2 | cv:C0752166 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 4.81e-03 | 18 | 171 | 2 | OBA_2045065 | |
| Disease | sleep duration | 5.33e-03 | 362 | 171 | 7 | EFO_0005271 | |
| Disease | diet measurement, HOMA-B | 5.35e-03 | 19 | 171 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 5.35e-03 | 19 | 171 | 2 | EFO_0802076 | |
| Disease | FEV/FEC ratio | STARD13 SELPLG JCAD ERBB3 CDH23 CRTC1 MCM7 WWTR1 ACVR1 HAPLN1 SPTBN5 PPARGC1A NELL2 ACAN TNXB | 5.36e-03 | 1228 | 171 | 15 | EFO_0004713 |
| Disease | Colorectal Neoplasms | 5.68e-03 | 277 | 171 | 6 | C0009404 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASSVELEVLGQDDSG | 371 | Q7L8C5 | |
| IVAGLSVETLEGTTL | 321 | Q15582 | |
| SVETLEGTTLEVGCS | 326 | Q15582 | |
| STLVLGEGATEAEIS | 66 | P02760 | |
| TDSVVIFSGEGSDEL | 356 | P08243 | |
| TLSSVGLSSVLGTEE | 1176 | P21860 | |
| VVALGASSSEEVELE | 166 | O75150 | |
| LATIDTGDAEISITS | 146 | Q96KC9 | |
| SILSDGDIGVDISLT | 221 | P11597 | |
| LDAAGIEEAITAVGS | 381 | Q9UJX5 | |
| GVQSDEIDLSDVLSG | 1526 | Q9NR09 | |
| TASSIIDEGLGEVGT | 2036 | P13611 | |
| AGTVITTADEIELEG | 2956 | P13611 | |
| TVLVGGRDIETSLDA | 986 | P78363 | |
| IIQGLTETGTDLEAV | 36 | Q7L1Q6 | |
| VTLTGEGQADLTLVS | 196 | Q00973 | |
| LGETANILETGETLE | 1431 | Q02952 | |
| NGTVESVEADGLTLD | 141 | Q9H175 | |
| TTADVEEITGEGLTA | 521 | Q9UIF9 | |
| LTSLTLGSGQAEEEE | 156 | Q12774 | |
| SLGDEELTLTEALVG | 391 | Q96QA5 | |
| TIEGLITTNVGDSTL | 166 | Q04771 | |
| LTSLTLGSGQAEEEE | 156 | A5YM69 | |
| SSELSLVGDTTGDTL | 2421 | Q92793 | |
| DAVDLSSAGTAGVLI | 4786 | Q86UQ4 | |
| LTATSDEEGSVLSIA | 791 | A6QL64 | |
| GFLGELTSSEVATEV | 341 | P10523 | |
| TGTGTLLITLEDVND | 566 | P55290 | |
| VTLEESLAEGGFSTV | 51 | Q9NSY1 | |
| VTATDEDSGLNGELV | 2091 | Q9H251 | |
| ALADTIATTSTDIGE | 1511 | Q9Y485 | |
| GDVIALSDITSSGAA | 246 | Q96CP6 | |
| ITLSVLEAAVSLGGE | 921 | Q8TBY9 | |
| FATEILGLTISEDSG | 1131 | Q8TBY9 | |
| IAIGTGTDVAIEAAD | 1316 | Q04656 | |
| SGTTATVALLRDGIE | 186 | Q8N3J5 | |
| DVDSDGSTDLVLIGA | 466 | P20702 | |
| GTVIALITVSDRDSG | 366 | Q9Y5H9 | |
| SSAETDSLLGGITVV | 831 | O60271 | |
| EALDGFIIAVTTDGS | 91 | Q99743 | |
| SEAEILTGLTVGSAA | 201 | Q9H477 | |
| TLNETLGSLSDAVVG | 396 | Q7RTW8 | |
| DLGVGEQITTVSAID | 581 | Q14517 | |
| GATVSEDILVGTEVL | 3236 | Q14517 | |
| SEDALLGSEIAQVTG | 2286 | Q96JQ0 | |
| LGSATLTIGISDIND | 301 | Q8N6Y1 | |
| VLDEAGSTVSTVGIS | 646 | Q9Y4B6 | |
| EGSLEETGELTVALV | 836 | M0R2J8 | |
| DVLTELELGESTTGV | 31 | Q99435 | |
| ITLDTATEIEGLSTG | 416 | Q86T24 | |
| GDGTLDVTITTLRDS | 351 | Q9P244 | |
| TLVEELTISGVLDSG | 1191 | Q2KJY2 | |
| ASELEGSLGEASTIE | 1061 | Q9P266 | |
| GDLDTGSALVLTIES | 3356 | Q2LD37 | |
| LGNTLTTLTGEEDID | 3471 | Q2LD37 | |
| VSSLDLEGESVSELG | 586 | Q14C86 | |
| VDLLIGGTETTANTL | 286 | P08686 | |
| VGDVILTVSATDEDG | 3336 | Q9NYQ8 | |
| SISLIVDSVEEGDLG | 316 | Q9NZN1 | |
| LGSTDGIIDAVATFS | 151 | Q96R28 | |
| LGSTDGIIDVVATFS | 151 | Q8NG83 | |
| LGSTDGIIDAVATFS | 151 | Q8NG81 | |
| VVGLETTELSAEGSG | 2921 | Q7Z5P9 | |
| TTGLSAEVTEITGIS | 3486 | Q7Z5P9 | |
| TGLSAEATEITGLSA | 3816 | Q7Z5P9 | |
| VTETIGLSAEATGTI | 4021 | Q7Z5P9 | |
| TLGLDVSVTISQDAG | 131 | Q9NXJ5 | |
| QDSESVLLVDEAGGS | 446 | P35408 | |
| GILEIESAEVSGNSV | 631 | Q96M96 | |
| TGTAETEILGTQEIA | 811 | Q8N3D4 | |
| IGGAVTATDGLSEEL | 151 | P25208 | |
| ISDIDGTITRSDTLG | 676 | Q14693 | |
| GLSADELIAIISSDG | 171 | Q2TBA0 | |
| ETGSLSTESIISGLQ | 406 | Q6ZVL6 | |
| VEAVDDITSETSGIL | 161 | O76027 | |
| SVDIDGDGVTDVLLV | 486 | Q9UKX5 | |
| SSSGGELEAGELVID | 296 | Q9UGU5 | |
| VLELGAETGVQSSDL | 276 | Q15070 | |
| TVLESVLVDDSELGG | 321 | Q9Y5Y4 | |
| DSVSGELTLEGGALV | 421 | P33993 | |
| AEILEGSASGVGDLS | 941 | P16112 | |
| VLETSTSAVGDLSGL | 1456 | P16112 | |
| VLEISVSGVEDISGL | 1476 | P16112 | |
| IAEVSGESSRAEIGS | 1901 | P16112 | |
| VLGSLSAVTTGLEDV | 931 | Q7Z442 | |
| EGGEVTFSVDLTVAS | 626 | Q5VST9 | |
| ERTLSVELSGTAGLT | 281 | Q9UBK2 | |
| GLAESTGLLAVSDEI | 201 | Q9NPB6 | |
| GTITFISEVESDGAV | 1676 | Q8NFC6 | |
| ASDIDAESITSGVEL | 626 | O95876 | |
| LGGTDDIQVLLDDST | 1051 | Q9C0G6 | |
| DIGSDVILLCSSEEG | 156 | Q5DX21 | |
| SGEITINTDDIDLAG | 551 | Q9BXC9 | |
| ASSLVEAVLISEGLG | 2116 | Q13936 | |
| DISSAGSISGDIIDE | 291 | Q15329 | |
| ELTSSLAGVGDVSFD | 576 | Q6UUV9 | |
| ITGLTISDLRTEDSG | 276 | Q8TD84 | |
| VLDDGSESEVVTAVG | 696 | Q05707 | |
| ISDGGQSAVSESLLV | 641 | Q9Y2H6 | |
| GSLDDTEADVLGLVA | 406 | Q6P531 | |
| ELEGLAGLATVATED | 686 | O95886 | |
| LESSGIGTEIIQVEA | 841 | Q8TDW7 | |
| GVFSIDSSSGIIILE | 3176 | Q8TDW7 | |
| LGGSSAATEAVAILT | 266 | Q9HCJ1 | |
| SLTVVSTFELGTEEG | 1081 | O75578 | |
| GTEEGSVLQLTEASR | 1091 | O75578 | |
| SAILTAQLDEELGGT | 506 | P06396 | |
| DVTVALELTTGDAGS | 506 | Q8NFI3 | |
| VDAALSDLEITLEGG | 346 | Q96AC1 | |
| VASLVLTTGLGASEA | 161 | A6NKX4 | |
| SLGGLSIDDINLSET | 411 | Q16820 | |
| SVGIISEGSETVEDI | 641 | P20648 | |
| SVTLGSSGEVDRLVA | 31 | O75474 | |
| VGTTDELSSAIGFAL | 86 | Q96EY8 | |
| GTVIALISVSDRDSG | 366 | Q9UN75 | |
| LEEDTLSEGSGVASL | 856 | Q7Z6I6 | |
| GGSDSDASLVITDLT | 116 | P10915 | |
| EGVSSVLLGVSSAEQ | 356 | O43448 | |
| ISSEGISLALVGAAS | 336 | Q8TC56 | |
| ETAEEAVTLGGSLDE | 781 | Q9Y4G2 | |
| TGLDAGGAVTELTTE | 91 | Q14242 | |
| TLEELGTQLEESGAT | 891 | Q9Y3M8 | |
| GTALAIVTSGELDSS | 736 | Q02446 | |
| VGELTGVNSDTILLD | 336 | Q96GJ1 | |
| IGESSIEGLTSVLST | 481 | Q6ZMZ0 | |
| VGDAILSVNGEDLSS | 131 | Q13424 | |
| EIGSLDEGISSSAIS | 301 | Q96DN5 | |
| DLTVTSRGLTDLEIG | 886 | Q14DG7 | |
| EQSGLSVTLESTGLA | 266 | Q969F9 | |
| EVGTDGLLATSLDAT | 471 | Q8IXI1 | |
| LITELTANEELTGTG | 76 | Q8IZX4 | |
| LTANEELTGTDGALV | 81 | P21675 | |
| NGEEGSLSLASVIIS | 2756 | Q96Q15 | |
| RAGTLTVEELGATLT | 2476 | P58107 | |
| RAGTLTVEELGATLT | 4611 | P58107 | |
| IAGDDSVTEGVTDLV | 546 | Q96HU1 | |
| GDGTTSVTVLAAELL | 96 | P78371 | |
| QDAEVGDGTTSVTLL | 86 | Q99832 | |
| AEAGSELEGVSLVTG | 211 | Q8TF17 | |
| SELTASALGSEVDGL | 1701 | O75592 | |
| DTGISEFVLLGLSEE | 6 | O14581 | |
| GTLDVVSVDLVTDSD | 41 | Q8NCF5 | |
| ADVSIEDSVISLSGD | 96 | P00441 | |
| DLEALGTLSLGTTEE | 286 | Q9NZQ3 | |
| TAELDSSLGTSVEVL | 596 | Q9NRC6 | |
| EGLVDTGADVSIIAL | 801 | P63128 | |
| LGLVGATADDTEAEL | 981 | Q15021 | |
| EIVLLTDGEDNTISG | 406 | A8K7I4 | |
| GVGGITLLTLSDTED | 296 | Q9H2X0 | |
| GSELVADSGVTIDTT | 901 | P35443 | |
| TSLAEAGAGITVLDA | 326 | Q6B0B8 | |
| NADITITDIISGLGS | 116 | Q9C0D3 | |
| IAELGQDLSGSITSD | 176 | Q8NI27 | |
| GLADGVEDLLDISSV | 1096 | Q8N2C7 | |
| EVDELLTGSTGISTV | 2431 | Q9C0A1 | |
| ESATVSDGELTGADL | 666 | O14924 | |
| LDVGVDTLTDGLSSL | 246 | Q9NR83 | |
| DISELLATGAGLSES | 226 | Q9NQ55 | |
| QLEGAEIGSTEITFT | 66 | O00442 | |
| GELAVAAVTSDSVGL | 3266 | P22105 | |
| AVAGETILVDGVSEE | 991 | Q92752 | |
| EEGDIAVSLGTSDTL | 291 | O75191 | |
| VLTGTDSETLGRVAE | 146 | Q6ZS81 | |
| ASETQILEGSLGISV | 1401 | P53804 | |
| GETCLIIEDVVTSGS | 116 | P11172 | |
| EIISESLGLSQDVAG | 96 | Q71RS6 | |
| AVSGSEELLGEDTID | 471 | Q6ZSY5 | |
| AAGEAEGDITLSTAE | 1701 | O95359 | |
| DADITEILSGVNSGL | 126 | Q9UJT2 | |
| SLLTLSSSEVGLEGV | 56 | Q8IWL8 | |
| FGLVGAEVSVSSLES | 381 | Q4ZJI4 | |
| SIGETVEEVTDSGFL | 486 | Q15393 | |
| STAITDDTLGGTLTI | 81 | Q9NZC2 | |
| TLGVVTSAEDTSGIL | 451 | P07949 | |
| GVDAVVIAIGESELS | 301 | Q8TCN5 | |
| EDLVATGTIGTLLSA | 46 | Q9UKP6 | |
| VTIEIVLSSSGDEDS | 351 | Q96IT1 | |
| ETQGESLESRVTLGS | 51 | Q9UJL9 | |
| LEGLVDTGADVSIIA | 21 | P63123 | |
| TVSLTDGSLATLEGI | 1346 | Q9UL36 | |
| SDILGATTEVLIEDS | 551 | Q96JP5 | |
| LEQVSSDEGIGTLAE | 4751 | Q5T4S7 | |
| AEIQEEVALTSLGSG | 761 | Q13308 | |
| DLLSSVDGGTSDEIQ | 101 | Q7Z3T8 | |
| IDLLSGTGFLEETSL | 231 | Q7Z402 | |
| GTNVDLGTLESEDLI | 366 | Q9GZV5 | |
| EDIITTGLQTTDGLA | 1116 | O75096 | |
| SEVTEEGLALGQEST | 466 | O15069 | |
| GQLLTILSVEDSDDG | 81 | O15146 | |
| LDGIVTDAIEASSIG | 241 | P29120 | |
| AGELETSDVVTVVLG | 31 | Q96NY8 |